* Roche announces first fda-approved cmv test for use in
hematopoietic stem cell transplant recipients
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +91 806 749 1136)
The post BRIEF-Roche Holding announces FDA-approved test for use in hematopoietic stem cell transplant recipients appeared first on NASDAQ.